期刊文献+

Pancreatic cancer–Surgery for recurrent disease

Pancreatic cancer–Surgery for recurrent disease
下载PDF
导出
摘要 Recurrence of pancreatic ductal adenocarcinoma (PDAC) after a resection with curative intent is inevitable in the majority of cases. Approximately three-quarters of patients ultimately die from metastatic, local, or combined tumor recurrence . This may be due to the insufficient control over the disease after resecting the tumor and/or the existence of micrometastases at the time of the initial diagnosis. Even multimodality approaches including surgery, neoadjuvant radio-chemotherapy, adjuvant therapy, and novel targeted therapies offer only limited benefit and are not able to prevent recurrence in most of the patients.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第2期159-161,共3页 中德临床肿瘤学杂志(英文版)
关键词 recurrent disease SURVIVAL pancreatic cancer SURGERY pancreatic resection MORBIDITY MORTALITY 胰腺癌 复发疾病 外科手术 死亡率 存活率
  • 相关文献

参考文献17

  • 1Yeo C J, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg, 1997, 225: 621-633, discussion 633-636.
  • 2Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg, 1991, 161: 120-124, discussion 124-125.
  • 3Yeo C J, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg, 1995, 221: 721-731, discussion 731-733.
  • 4Gudjonsson B, Livstone EM, Spiro HM. Cancer of the pancreas: diagnostic accuracy and survival statistics. Cancer, 1978, 42: 2494- 2506.
  • 5Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer, 1987, 60: 2284-2303.
  • 6Carpelan-Holmstrom M, Nordling S, Pukkala E, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study reevaluating the data of the Finnish Cancer Registry. Gut, 2005, 54: 385-387.
  • 7Nukui Y, Picozzi V J, Traverso LW. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg, 2000, 179: 367-371.
  • 8Traverso LW. Pancreatic cancer: surgery alone is not sufficient. Surg Endosc, 2006, 20 Suppl 2:S446-S449.
  • 9Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg, 2004, 91:586-594.
  • 10Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg, 2006, 244: 10-15.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部